Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | LNP@rosuvastatin-CY5.5, lipid nanoparticle-encapsulated rosuvastatin-CY5.5 complex |
| Catalog Number | R-CW-LLC005 |
| Alias | Liposome-loaded rosvastatin CY5.5 |
| Appearance | Light blue or colorless transparent liquid |
| Molecular Formula | N/A |
| Solubility | Soluble in organic solvents |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | drug delivery system |
| Specification | 10mg:Inquiry 25mg:Inquiry 50mg:Inquiry |
| Description | LNP@rosuvastatin-CY5.5 is an innovative drug delivery system that combines rosuvastatin (rosuvastatin) and CY5.5 fluorescent label through lipid nanoparticles (LNP) packaging. Rosuvastatin, as a selective HMG-CoA reductase inhibitor, mainly acts on the liver and can effectively lower cholesterol, reduce low-density lipoprotein cholesterol (LDL-C) levels, and increase high-density lipoprotein cholesterol (HDL-C) levels. It is commonly used to treat primary hypercholesterolemia, mixed dyslipidemia and prevent cardiac blood vessel diseases. CY5.5, as a fluorescent marker, gives this preparation fluorescent tracing properties and can be used to monitor drug distribution, metabolism and other processes in biomedical research. Lipid nanoparticles protect drugs, improve drug stability and bioavailability, and promote cellular uptake, helping to deliver rosuvastatin to target cells or tissues more efficiently. |